Is the "100% effective against solid tumors" cancer pill AOH1996 paper legit? [see description]
Forecasting market: Is the "100% effective against solid tumors" cancer pill AOH1996 paper legit? [see description]
Alpha Opportunity
Alpha Thesis
We REVISE UP to 70% (from 29%) for the AOH1996 paper being legitimate. Phase 1 clinical trials at City of Hope show real results: 49% tumor shrinkage in pancreatic liver metastases, no significant toxicity, and a new March 2026 NSCLC study (Frontiers in Pharmacology) confirming anti-cancer activity. The original paper appears to be well-supported by subsequent clinical evidence.
📐Key Metrics
Key Findings
- Phase 1 clinical trials ACTIVE at City of Hope. FDA-approved trials = real drug.
- 49% tumor shrinkage in pancreatic cancer liver metastases (2 patients, April 2025).
- No significant toxicity observed. Consistent with preclinical animal studies.
- New NSCLC study published March 2026 (Frontiers in Pharmacology) confirms anti-cancer activity.
- PCNA-targeting mechanism has strong scientific basis.
Full Research Report
Unlock the complete analysis including probability assessment, Bayesian calculations, resolution rigor analysis, and strategic positioning recommendations across 5+ dimensions.
Toggle to Pro in the top bar to access the full report
Alpha Quality Factors
Criteria that determine how exploitable this mispricing is
Human Bias Detected
Cognitive biases creating this alpha opportunity
The crowd may lack specialized knowledge that narrows the true probability range.
Compare Markets
Searching Polymarket, Kalshi, Manifold & Metaculus…
Market Data
Position Sizing
Kelly Criterion (per $1,000 bankroll)